MX9800407A - Nuevos derivados de galantamina, su procedimiento de preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contiene. - Google Patents

Nuevos derivados de galantamina, su procedimiento de preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contiene.

Info

Publication number
MX9800407A
MX9800407A MX9800407A MX9800407A MX9800407A MX 9800407 A MX9800407 A MX 9800407A MX 9800407 A MX9800407 A MX 9800407A MX 9800407 A MX9800407 A MX 9800407A MX 9800407 A MX9800407 A MX 9800407A
Authority
MX
Mexico
Prior art keywords
derivatives
pharmaceutical compositions
compositions containing
drugs
preparation
Prior art date
Application number
MX9800407A
Other languages
English (en)
Other versions
MXPA98000407A (es
Inventor
Claude Thal
Catherine Guillou
Aude Mary
Dolor Renko
Pierre Rotier
Yves Christen
Original Assignee
Conseils De Rech S Et Soc D
Applic Scient D
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Conseils De Rech S Et Soc D, Applic Scient D, Scras filed Critical Conseils De Rech S Et Soc D
Publication of MXPA98000407A publication Critical patent/MXPA98000407A/es
Publication of MX9800407A publication Critical patent/MX9800407A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La presente invencion es concerniente con nuevos derivados de gelantamina de formulas generales (Ia) y (Ib), un procedimiento para su preparacion, composiciones farmacéuticas que los contienen y su uso en particular como inhibidores de la colinesterasa.
MX9800407A 1995-07-19 1996-07-19 Nuevos derivados de galantamina, su procedimiento de preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contiene. MX9800407A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9514821.9A GB9514821D0 (en) 1995-07-19 1995-07-19 Galanthamine derivatives
GB9514821.9 1995-07-19
PCT/FR1996/001139 WO1997003987A1 (fr) 1995-07-19 1996-07-19 Nouveaux derives de la galanthamine, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant

Publications (2)

Publication Number Publication Date
MXPA98000407A MXPA98000407A (es) 1998-04-01
MX9800407A true MX9800407A (es) 1998-04-30

Family

ID=10777948

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9800407A MX9800407A (es) 1995-07-19 1996-07-19 Nuevos derivados de galantamina, su procedimiento de preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contiene.

Country Status (16)

Country Link
US (1) US5958903A (es)
EP (1) EP0839149B9 (es)
JP (1) JP4177894B2 (es)
AT (1) ATE264332T1 (es)
AU (1) AU6662396A (es)
CA (1) CA2227235C (es)
DE (1) DE69632194T2 (es)
DK (1) DK0839149T3 (es)
ES (1) ES2218596T3 (es)
GB (1) GB9514821D0 (es)
IL (1) IL122739A0 (es)
MX (1) MX9800407A (es)
NO (1) NO980215D0 (es)
PT (1) PT839149E (es)
WO (1) WO1997003987A1 (es)
ZA (1) ZA966163B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1891954A3 (en) * 1998-09-30 2009-01-14 Takeda Pharmaceutical Company Limited Acetylcholinesterase inhibitors for improving excretory potency of urinary bladder
WO2000030446A1 (en) * 1998-11-23 2000-06-02 Bonnie Davis Dosage formulations for acetylcholinesterase inhibitors
CA2358062C (en) 1998-12-24 2006-12-19 Janssen Pharmaceutica N.V. Controlled release galantamine composition
ATE355066T1 (de) * 1999-01-11 2006-03-15 Atanas Russinov Djananov Nahrungszusatz aus kräutern zur steigerung der muskulären kraft und ausdauer von athleten
US8603546B2 (en) * 1999-01-11 2013-12-10 Herbaceuticals Inc. Herbal supplement for increased muscle strength and endurance for athletes
US6372760B1 (en) * 1999-03-31 2002-04-16 Eisai Co., Ltd. Stabilized composition comprising antidementia medicament
DE50101827D1 (de) * 2000-03-31 2004-05-06 Sanochemia Pharmazeutika Ag Wi Neue derivate und analoga von galanthamin
DE10129265A1 (de) * 2001-06-18 2003-01-02 Hf Arzneimittelforsch Gmbh Wirkstoff-Kombination zur medikamentösen Sucht- oder Rauschmitteltherapie
JP4721386B2 (ja) * 2001-07-10 2011-07-13 第一三共株式会社 新規ガランタミン類縁体
DE10134038A1 (de) * 2001-07-12 2003-02-06 Hf Arzneimittelforsch Gmbh Wirkstoff-Kombination zur medikamentösen Therapie der Nikotinabhängigkeit
CA2479394A1 (en) * 2002-03-25 2003-10-02 Ulrich Jordis Process for the production of norgalanthamine, and isomers, salts and hydrates thereof
CA2506282A1 (en) * 2003-09-29 2005-04-07 Sanochemia Pharmazeutika Ag Use of galanthamine and the derivatives thereof in the production of medicaments
AT414125B (de) * 2003-09-29 2006-09-15 Sanochemia Pharmazeutika Ag Neue derivate des 4a,5,9,10,11,12-hexahydro- benzofuro(3a,3,2)(2) benzazepin, verfahren zu deren herstellung sowie deren verwendung zur herstellung von arzneimitteln
WO2005065661A2 (en) * 2003-12-31 2005-07-21 Actavis Group Hf Immediate, controlled and sustained release formulations of galanthamine
CA2552114A1 (en) * 2003-12-31 2005-07-21 Actavis Group Hf Solid dosage formulations of galantamine
PL1895994T3 (pl) * 2005-05-13 2011-02-28 Alza Corp Wielowarstwowy system podawania leków z barierą zabezpieczającą przed wypływaniem materiału ze zbiornika
WO2007035941A2 (en) * 2005-09-23 2007-03-29 Alza Corporation Transdermal galantamine delivery system
JP5752598B2 (ja) 2008-09-11 2015-07-22 アイ．ビー．アール． イスラエリ バイオテクノロジー リサーチ リミテッド レウコユム球根の抽出物及びその利用
CN102573848A (zh) * 2009-04-24 2012-07-11 济州大学校产学协力团 含有去甲加兰他敏化合物作为活性成分的用于预防和治疗脱发症的组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663318A (en) * 1986-01-15 1987-05-05 Bonnie Davis Method of treating Alzheimer's disease
US4735169A (en) * 1986-09-03 1988-04-05 Nordson Corporation Adhesive applicator assembly
ATE411026T1 (de) * 1987-05-04 2008-10-15 Bonnie Davis Mittel zur behandlung der alzheimer-krankheit
US5336675A (en) * 1991-05-14 1994-08-09 Ernir Snorrason Method of treating mania in humans
US6323195B1 (en) * 1993-10-15 2001-11-27 Aventis Pharmaceuticals Inc. Galanthamine derivatives as acetylcholinesterase inhibitors
US5428159A (en) * 1994-04-08 1995-06-27 Ciba-Geigy Corporation Method of manufacture of (-)-galanthamine in high yield and purity substantially free of epigalanthamine

Also Published As

Publication number Publication date
US5958903A (en) 1999-09-28
DE69632194D1 (de) 2004-05-19
WO1997003987A1 (fr) 1997-02-06
NO980215L (no) 1998-01-16
JP4177894B2 (ja) 2008-11-05
CA2227235A1 (fr) 1997-02-06
ZA966163B (en) 1997-02-10
DE69632194T2 (de) 2005-03-17
JPH11509541A (ja) 1999-08-24
CA2227235C (fr) 2010-08-31
EP0839149B9 (fr) 2005-03-09
IL122739A0 (en) 1998-08-16
ATE264332T1 (de) 2004-04-15
GB9514821D0 (en) 1995-09-20
ES2218596T3 (es) 2004-11-16
EP0839149B1 (fr) 2004-04-14
NO980215D0 (no) 1998-01-16
PT839149E (pt) 2004-08-31
DK0839149T3 (da) 2004-08-09
EP0839149A1 (fr) 1998-05-06
AU6662396A (en) 1997-02-18

Similar Documents

Publication Publication Date Title
MX9800407A (es) Nuevos derivados de galantamina, su procedimiento de preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contiene.
HUP9901304A3 (en) Piperazine and piperidine derivatives with analgesic effect, process for their preparation and pharmaceutical compositions containing them
AU4821096A (en) Benzazepine-, benzoxazepine- and benzothiazepine-N-acetic derivatives, process for their preparation and pharmaceutical compositions containing them
IL117598A (en) Quinazoline derivatives, process for their preparation and pharmaceutical compositions containing them
HUP9802200A3 (en) Rapamycin derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP9901079A3 (en) 5- and 6-membered cyclic compounds containing nitrogenatom, pharmaceutical compositions containing them, their use for producing pharmaceutical compositions and their producing
HUP9602122A2 (en) Camptothecin derivatives, process for the preparation thereof and pharmaceutical compositions containing them
HUP9700358A3 (en) New oxazolidinon derivatives, process for their preparation and pharmaceutical compositions containing them
IL117104A (en) Tetrahydrocarbazole derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0100731A3 (en) New oxazolidine-, thiazolidine-, pyrrolidine-and piperidin derivatives process for their preparation and pharmaceutical compositions containing them
HUP9900056A2 (hu) Szubsztituált 4-fenil-amino-tiazol-származékok, eljárás előállításukra és ilyen vegyületeket tartalmazó gyógyászati készítmények
HUT70544A (en) Heteroaryl-amines as acetyl-cholinesterase inhibitors, pharmaceutical compositions comprising them and process for their preparation
HUP9702400A3 (en) Substituted camptothecin derivatives, process for their preparation and pharmaceutical compositions containing them
IL109703A0 (en) Substituted carbazole derivatives, processes for their preparation and pharmaceutical compositions containing them
HUP9602635A2 (en) 4-aciloxy-benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing them
MX9800408A (es) Sales de derivados de amidina y de inhibidor de ciclooxigenasa, su procedimiento de preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.
HUP9904063A3 (en) Pde iv inhibiting 2-(cyanoimino)imidazole derivatives, their use, process for producing them and pharmaceutical compositions containing them
HUP9801993A3 (en) Ascomycin derivatives and their use for preparation of pharmaceutical compositions, process for their preparation and pharmaceutical compositions containing them
AU2841199A (en) Novel bis-benzamide derivatives, method for making same pharmaceutical compositions containing them and use thereof as medicine
HUP9601062A3 (en) Chromone derivatives, pharmaceutical compositions containing them and process for their preparation
MX9708394A (es) Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion.
AU8031598A (en) 3-aminoindane derivatives, process for their preparation and pharmaceutical compositions containing them
HUP9600173A3 (en) 4-amino-benzoyl-guanidine derivatives, process for preparing them and pharmaceutical compositions containing them
AU7305496A (en) Novel acid pyrazole derivatives, preparation method therefor, use thereof as drugs, novel use therefor, and pharmaceutical compositions containing such derivatives
GEP20012518B (en) Novel Erythromycin Derivatives, Method for Their Preparation and Their Use as Medicine